The joint guidance was created to ensure drug developers employ best practices when using AI.

For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...

When you think of tools for studying substance use and addiction, a social media site like Reddit, TikTok or YouTube probably ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI)[1] models in drug development and in regulatory submissions titled, ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

In April, the US Food & Drug Administration (FDA) announced its decision to phase out animal testing requirements for ...